Opendata, web and dolomites

LUCINE SIGNED

LUCINE: THE COMPREHENSIVE, PERSONALIZED AND SAFE eHEALTH SOLUTION THAT ACCURATELY MEASURES, ANALIZES AND RELIEVES PAIN

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LUCINE project word cloud

Explore the words cloud of the LUCINE project. It provides you a very rough idea of what is the project "LUCINE" about.

immersive    not    relies    digital    gt    data    utilises    becomes    time    pain    professionals    patient    22    pharmacy    approximately    first    primary    subjective    expectations    45    consults    tools    sufferfrom    revolutionary    levels    europeans    treatment    personal    phenomenon    relieve    seconds    company    facets    solutions    vocal    clinically    care    habits    limit    physicians    health    patients    variety    million    postural    social    billion    adversely    smartphone    person    camera    collected    accounts    mobile    provides    solution    represented    illness    nition    daily    individuals    customized    vr    economic    dramatic    attitudes    appointments    validated    chronic    interfering    public    diagnosis    offers    tastes    lack    adult    world    lucine    profile    recog    impacts    pandemic    environmental    market    life    global    movements    microphone    adapts    quality    personalised    facial    culture    environment    healthcare    350    innovator    441   

Project "LUCINE" data sheet

The following table provides information about the project.

Coordinator
LUCINE SAS 

Organization address
address: 2 PLACE DE LA BOURSE
city: BORDEAUX
postcode: 33000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUCINE SAS FR (BORDEAUX) coordinator 50˙000.00

Map

 Project objective

LUCINE is a revolutionary, clinically validated, solution for chronic pain diagnosis and management. Chronic pain is a global pandemic that affects 100 million Europeans. The management of pain is not adapted to the needs of the patients or the expectations of health professionals. When it becomes chronic, pain becomes an illness and has dramatic social, economic and public health impacts. Each year, approximately 1 in 5 Europeans are affected by chronic pain. Chronic pain adversely affects patient’s quality of life and can even limit a person’s movements, further interfering with daily activities. Health professionals lack the time and the tools to address a phenomenon as personal and subjective as pain. Still, chronic pain accounts for 22% of primary care physicians consults, with over a third of adult appointments involving a patient in chronic pain. The cost of pain at the European level can be estimated at € 441 billion. As a company, LUCINE is a leading innovator on pain diagnosis and management. LUCINE ́s customized mobile application is the first digital solution that can measure and analyse all facets of a patient’s pain, in 45 seconds. It utilises the smartphone’s camera and microphone to measure a patient’s pain levels through facial, postural, vocal and environmental recog¬nition. It provides an objective measurement of the patient’s pain level on a scale of 1 to 100. Moreover, LUCINE is the first “digital pharmacy” that offers personalised immersive healthcare solutions to relieve pain. Yet it relies on existing “devices” (smartphone, VR sets), by offering a variety of care adapted to the environment, pain levels and patient’s profile. Based on the data collected our system adapts the treatment to the tastes, attitudes, habits, and culture of the user. LUCINE’s products are targeting a large global market of € >350 billion represented by the over 1.5 billion individuals across the world who sufferfrom this type of pain.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LUCINE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LUCINE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

Click and Spray (2020)

A SIMPLER, CHEAPER AND EASIER TO RECYCLE AEROSOL CONTAINER

Read More